Skip to content
  • February 13, 2026
EuroAsia24 News EuroAsia24 News
×
EuroAsia24 News EuroAsia24 News
  • Home
  • Global
  • Political
  • Defense
  • Business
  • Health
  • Sports
  • Tech
  • Entertainment
  • Lifestyle
  • Home
  • pharmaceuticals
Advertisment
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia
Business

Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia

The Editorial Team July 21, 2025 Acquires, AI stock, Biotechnology, Bone, disorder, full, Hypophosphatasia, joint venture, Oral, pharmaceuticals, potential, protective masks, Rallybio Corporation, Rare, Recursion, Recursion Pharmaceuticals Inc, REV102, rights, Therapy

[ad_1] Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to…

Read More
Acadia Pharmaceuticals price target raised to  from  at Oppenheimer
Business
The Editorial Team Acadia, Acadia Pharmaceuticals, Oppenheimer, pharmaceuticals, price, raised, target 0 Comments

Acadia Pharmaceuticals price target raised to $19 from $17 at Oppenheimer

[ad_1] Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $19 from $17…

Read More
May 17, 2025
Acadia Pharmaceuticals price target raised to  from  at Oppenheimer
Business
The Editorial Team Amneal, call, Earnings, pharmaceuticals, Presentation, results 0 Comments

Amneal Pharmaceuticals, Inc. 2024 Q4 – Results – Earnings Call Presentation

[ad_1] This article was written byFollowSeeking Alpha's transcripts team is responsible for the development of…

Read More
February 28, 2025
Madrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 Earnings
Business
The Editorial Team Earnings, Establish, finally, Madrigal, pharmaceuticals, position 0 Comments

Madrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 Earnings

[ad_1] This article was written byFollowBiologics is a full-time healthcare investor who developed a passion…

Read More
October 28, 2024
Why is the market design for innovative pharmaceuticals not well understood?
Health
The Editorial Team design, Innovative, market, pharmaceuticals, understood 0 Comments

Why is the market design for innovative pharmaceuticals not well understood?

[ad_1] That is the title of a fantastic editorial from Olivença et al. (2024). A…

Read More
September 17, 2024
These high-dividend-yielding stocks could see a rebound as rates decline, BMO says
Business
The Editorial Team Abbvie Inc, American Electric Power Company Inc, BMO, business news, CME Group Inc, decline, Digital Realty Trust Inc, Dividends, highdividendyielding, Host Hotels & Resorts Inc, investment strategy, Pfizer Inc., pharmaceuticals, rates, Real estate, rebound, REITs, S&P 500 Index, Southern Co, Stock markets, Stocks, Utilities 0 Comments

These high-dividend-yielding stocks could see a rebound as rates decline, BMO says

[ad_1] Now could be a good time to start buying stocks with high dividend yields,…

Read More
August 7, 2024
These high-dividend-yielding stocks could see a rebound as rates decline, BMO says
Business
The Editorial Team board, company, Determines, Directors, Interests, pharmaceuticals, Proposals, shareholders, Takeover, Unsolicited, Vanda 0 Comments

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

[ad_1] WASHINGTON, June 19, 2024 /PRNewswire/ -- Vanda (NASDAQ:) Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today…

Read More
June 20, 2024
Madrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 Earnings
Business
The Editorial Team beats, Biotech and Pharmaceuticals, Biotechnology, Breaking News, business, business news, Earnings, Eli, Eli Lilly and Co, fullyear, Guidance, Health care industry, hikes, Lilly, Mounjaro, pharmaceuticals, Profit, quarterly, sales, Strong, United States, Zepbound 0 Comments

Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro

[ad_1] Eli Lilly logo is shown on one of the company's offices in San Diego,…

Read More
April 30, 2024
Why is the market design for innovative pharmaceuticals not well understood?
Health
The Editorial Team abbott labs, accelerator, advanced cellular technology, amyotrophic lateral sclerosis, Applaud, Bidens, Cambridge, Cancer, certified emr, china, dc, dealflow, diabetes, diagnostic platforms, diagnostics company, doctors, ehr, electronic health records, electronic medical records, embryonic stem cells, employee wellness programs, emr, Execs, Executive, foodborne pathogens, geron corporation, Health, health and wellness, healthcare innovation, healthcare it, healthways, hospitals, humira, investing, laser surgery, life sciences, lou gehrig, massachusetts, md anderson cancer center, mdt, medcity news, medical devices, medtronic, minimally invasive surgery, minneapolis, minnesota, motion sensors, obesity, Order, overweight, patient monitoring system, pharmaceuticals, publics, r&d, renal denervation, rock health, san francisco, shanghai innovation center, skin disorders, st. jude medical, startup advice, startup funding, startups, stj, texas, twin cities, ulcerative colitis, washington, weight loss, wellness, wellpoint, Womens 0 Comments

Health Execs Applaud Biden’s Executive Order on Women’s Health

[ad_1] The White House has taken yet another step to advance women’s health. After launching…

Read More
March 20, 2024
Milu Health Raises .8M for AI-Driven Health Savings Platform
Health
The Editorial Team 4.8M, abbott labs, accelerator, advanced cellular technology, AIdriven, amyotrophic lateral sclerosis, Cambridge, Cancer, certified emr, china, dc, dealflow, diabetes, diagnostic platforms, diagnostics company, doctors, ehr, electronic health records, electronic medical records, embryonic stem cells, employee wellness programs, emr, foodborne pathogens, geron corporation, Health, health and wellness, healthcare innovation, healthcare it, healthways, hospitals, humira, investing, laser surgery, life sciences, lou gehrig, massachusetts, md anderson cancer center, mdt, medcity news, medical devices, medtronic, Milu, minimally invasive surgery, minneapolis, minnesota, motion sensors, obesity, overweight, patient monitoring system, pharmaceuticals, platform, publics, r&d, Raises, renal denervation, rock health, san francisco, savings, shanghai innovation center, skin disorders, st. jude medical, startup advice, startup funding, startups, stj, texas, twin cities, ulcerative colitis, washington, weight loss, wellness, wellpoint 0 Comments

Milu Health Raises $4.8M for AI-Driven Health Savings Platform

[ad_1] Rising healthcare costs are a major concern for employers in 2024 as they battle…

Read More
March 18, 2024

Posts pagination

1 2 … 6

CATEGORIES

  • Archive
  • Business
  • Defense
  • Entertainment
  • Global News
  • Health
  • Israel News
  • Lifestyle
  • Opinion
  • Political
  • Society
  • Sports
  • Technology
Advertisment
Eurasia24.com
  • About us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Euroasia24 is not responsible for the content of external sites. | Powered By SpiceThemes